<VariationArchive VariationID="2041795" VariationName="NM_000346.4(SOX9):c.334_335del (p.Phe112fs)" VariationType="Deletion" Accession="VCV002041795" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2102267" VariationID="2041795">
      <GeneList>
        <Gene Symbol="LOC108021846" FullName="SOX9 promoter region" GeneID="108021846" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72120285" stop="72122691" display_start="72120285" display_stop="72122691" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SOX9" FullName="SRY-box transcription factor 9" GeneID="6662" HGNC_ID="HGNC:11204" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>17q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72121020" stop="72126416" display_start="72121020" display_stop="72126416" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="70117160" stop="70122560" display_start="70117160" display_stop="70122560" Strand="+" />
          </Location>
          <OMIM>608160</OMIM>
          <Haploinsufficiency last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX9">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2023-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SOX9">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000346.4(SOX9):c.334_335del (p.Phe112fs)</Name>
      <CanonicalSPDI>NC_000017.11:72121724:TT:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="72121725" stop="72121726" display_start="72121725" display_stop="72121726" variantLength="2" positionVCF="72121724" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="70117866" stop="70117867" display_start="70117866" display_stop="70117867" variantLength="2" positionVCF="70117865" referenceAlleleVCF="CTT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>F112fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.70117866_70117867del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.70117866_70117867del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.72121725_72121726del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.72121725_72121726del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012490.1" sequenceAccession="NG_012490" sequenceVersion="1" change="g.5706_5707del">
            <Expression>NG_012490.1:g.5706_5707del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050876.1" sequenceAccession="NG_050876" sequenceVersion="1" change="g.1541_1542del">
            <Expression>NG_050876.1:g.1541_1542del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000346.4" sequenceAccession="NM_000346" sequenceVersion="4" change="c.334_335del" MANESelect="true">
            <Expression>NM_000346.4:c.334_335del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000337.1" sequenceAccession="NP_000337" sequenceVersion="1" change="p.Phe112fs">
            <Expression>NP_000337.1:p.Phe112fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000346.4(SOX9):c.334_335del (p.Phe112fs) AND Camptomelic dysplasia" Accession="RCV002903248" Version="2">
        <ClassifiedConditionList TraitSetID="633">
          <ClassifiedCondition DB="MedGen" ID="C1861922">Camptomelic dysplasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-12-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-12-13" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="633" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="646" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CMPD1/SRA1</ElementValue>
                <XRef Type="MIM" ID="114290" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Campomelic Dysplasia</ElementValue>
                <XRef ID="NBK1760" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Camptomelic dysplasia</ElementValue>
                <XRef ID="74928006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMPD1</ElementValue>
                <XRef Type="MIM" ID="114290" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">CMD1</ElementValue>
                <XRef Type="MIM" ID="114290" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">CMPD</ElementValue>
                <XRef Type="MIM" ID="114290" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10027" />
                <XRef ID="10027" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Campomelic dysplasia (CD) is a skeletal dysplasia characterized by distinctive facies, Pierre Robin sequence with cleft palate, shortening and bowing of long bones, and clubfeet. Other findings include laryngotracheomalacia with respiratory compromise and ambiguous genitalia or normal female external genitalia in most individuals with a 46,XY karyotype. Many affected infants die in the neonatal period; additional findings identified in long-term survivors include short stature, cervical spine instability with cord compression, progressive scoliosis, and hearing impairment.</Attribute>
                <XRef ID="NBK1760" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301724</ID>
                <ID Source="BookShelf">NBK1760</ID>
              </Citation>
              <XRef ID="140" DB="Orphanet" />
              <XRef ID="C1861922" DB="MedGen" />
              <XRef ID="MONDO:0007251" DB="MONDO" />
              <XRef Type="MIM" ID="114290" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5937406" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="15391160|MedGen:C1861922" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003248925" DateUpdated="2024-02-20" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-12-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant has not been reported in the literature in individuals affected with SOX9-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe112Hisfs*139) in the SOX9 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 398 amino acid(s) of the SOX9 protein. This variant disrupts a region of the SOX9 protein in which other variant(s) (p.Arg394*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SOX9" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.70117866_70117867del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1861922" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5937406" TraitType="Disease" MappingType="XRef" MappingValue="C1861922" MappingRef="MedGen">
        <MedGen CUI="C1861922" Name="Camptomelic dysplasia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

